Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

AirPal Expands Line of Air-Activated Transfer Pads to Include Multi-Purpose Patient Positioning Functionality

August 18, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

NORTH WALES, Pa., Aug. 18 /- AirPal ®, a leading innovator and supplier of lateral air transfer and positioning technology, has announced the expansion of its line of air-activated transfer pads to incorporate multi-purpose patient positioning functionality. "This announcement marks...

Advanced Life Sciences to Participate in Key Infectious Disease Conference

August 17, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Aug. 17 /- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the...

VirtuOx and Watermark Medical Announce Strategic Alliance to Expand Sleep Apnea Home Sleep Testing Solutions

August 17, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

CORAL SPRINGS, Fla., Aug. 17 /- VirtuOx, Inc., a medical technology services company and industry leader in delivering home sleep testing solutions, today announced an agreement with Watermark Medical, a privately-held, medical products and services company currently servicing the...

Advertisement

Oridion to Present Results to New Study for the Integrated Pulmonary Index(TM) at ATACCC Conference

August 17, 2010 12:32 am | by Bio-Medicine.Org | News | Comments

Oridion to Present Results to New Study for the Integrated Pulmonary... -- JERUSALEM and NEEDHAM, Massachusetts, August 17, 2010 /-

Springer adds Neurotherapeutics to journals portfolio

August 16, 2010 10:33 am | by EurekAlert | News | Comments

(Springer) Beginning in 2011, Springer will publish Neurotherapeutics, the official Journal of the American Society for Experimental NeuroTherapeutics. With the switch to Springer, Neurotherapeutics will change its format of publishing review articles only to offering original research...

PRA International Hosts Audio Conference on CV Drug Development

August 16, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

RALEIGH, N.C., Aug. 16 /- PRA International, a leading Clinical Research Organization, will host an audio conference on strategies for successful cardiovascular (CV) drug development on 24 August 2010 at 11:30 am (EDT). Dr. Michael Kirchengast, Vice President and Head of PRA's Scientific...

North American Spine Welcomes Robert R. Bulger, M.D. to Dallas Physician Group

August 16, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

DALLAS, Aug. 16 /- North American Spine is pleased to announce that Robert R. Bulger, M.D. has joined our group to help further the advancement of minimally invasive back pain treatment techniques.  The AccuraScope™ Discectomy and Neural Decompression (D.N.D.) procedure treats...

Rising Burden of Diseases Drives the Pharmaceutical Industry in East Africa, Says Frost & Sullivan

August 16, 2010 2:32 am | by Bio-Medicine.Org | News | Comments

CAPE TOWN, South Africa, Aug. 16 /- Infectious diseases are rampant in sub-Saharan Africa. Urbanisation and westernised lifestyles have further increased the prevalence of non-communicable diseases such as cancer. The strong correlation between infectious diseases and cancer has...

Advertisement

Drugs encased in nanoparticles travel to tumors on the surface of immune-system cells

August 15, 2010 11:31 am | by EurekAlert | News | Comments

(Massachusetts Institute of Technology) Now a team of MIT engineers has devised a way to deliver the necessary drugs by smuggling them on the backs of the cells sent in to fight the tumor. That way, the drugs reach only their intended targets, greatly reducing the risk to the patient.

Estrogen not associated with lung cancer incidence and mortality among postmenopausal women

August 13, 2010 2:31 pm | by EurekAlert | News | Comments

(Journal of the National Cancer Institute) Use of estrogen alone did not increase lung cancer mortality in postmenopausal women, according to a study published online Aug. 13 in the Journal of the National Cancer Institute.

Acetaminophen use in adolescents linked to doubled risk of asthma

August 13, 2010 3:31 am | by EurekAlert | News | Comments

(American Thoracic Society) New evidence linking the use of acetaminophen to development of asthma and eczema suggests that even monthly use of the drug in adolescents may more than double risk of asthma in adolescents compared to those who used none at all; yearly use was associated with...

Free statins with fast food could neutralize heart risk, scientists say

August 12, 2010 8:31 am | by EurekAlert | News | Comments

(Imperial College London) Fast food outlets could provide statin drugs free of charge so that customers can neutralize the heart disease dangers of fatty food, researchers at Imperial College London suggest in a new study published this week.

AACR Hosts Cancer Disparities Conference in Miami, Fla.

August 12, 2010 5:33 am | by AACR | News | Comments

PREMIER INTERNATIONAL CONFERENCE WILL HIGHLIGHT ADVANCES IN SCIENCE, COMMUNICATION AND UNDERSTANDING OF CANCER DISPARITIES. MIAMI, FLA. - SEPT. 30-OCT. 3, 2010 What: Advances in cancer treatment and management have not affected all socioeconomic groups equally, as data shows minority...

Advertisement

Spinal muscular atrophy may also affect the heart

August 10, 2010 9:33 pm | by EurekAlert | News | Comments

(Nationwide Children's Hospital) Along with skeletal muscles, it may be important to monitor heart function in patients with spinal muscular atrophy (SMA). These are the findings from a study conducted by Nationwide Children's Hospital and published online ahead of print in Human...

Tattooing linked to higher risk of hepatitis C: UBC study

August 6, 2010 6:35 am | by EurekAlert | News | Comments

(University of British Columbia) Youth, prison inmates and individuals with multiple tattoos that cover large parts of their bodies are at higher risk of contracting hepatitis C and other blood-borne diseases, according to a University of British Columbia study.

Cornerstone Therapeutics Announces Development of Generic for Tussionex®

August 5, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

CARY, N.C. , Aug. 5 /- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) ("Cornerstone" or the "Company"), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its...

Advanced Life Sciences Featured as Special Stock Pick by KonLin Investment Letter

August 5, 2010 5:33 am | by Bio-Medicine.Org | News | Comments

CHICAGO , Aug. 5 /- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the...

UT Southwestern's cancer center earns National Cancer Institute designation

August 4, 2010 10:34 am | by EurekAlert | News | Comments

(UT Southwestern Medical Center) The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center has attained National Cancer Institute designation, an elite distinction held by only 65 other cancer centers nationwide.

Parents should help teens get back on right sleep track

August 4, 2010 10:34 am | by Baylor College of Medicine | News | Comments

Computers, televisions and cell phones are preventing your teen from getting enough sleep, and that can affect grades and day to day life, said a sleep expert at Baylor College of Medicine . "Because teens tend to stay up and wake up later in the summer, their bodies get used to it,...

OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year

August 2, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , Aug. 2 /- Novalar Pharmaceuticals, Inc., a specialty pharmaceutical company focused in dental, today announced that OraVerse®, the company's premier pharmaceutical product, has again been selected by leading dental industry magazine Dentistry Today as one of its 'Top 100...

Cornerstone Therapeutics Announces Collaboration with The Cough Company

August 2, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

CARY, N.C. , Aug. 2 /- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) ("Cornerstone" or the "Company"), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that the...

Netcall join with Telephonetics VIP to deliver a wide and compelling suite of contact centre and enterprise communication solutions

July 30, 2010 7:36 am | by RealWire | News | Comments

Q-Max Workforce Management Software integrated with the Telephonetics VIP SEMAP+ communications platformNetcall QueueBuster® and CallMeBack™ integrated with Telephonetics VIP SEMAP+Datadialogs Eden helps bring together disparate systems into a single unified...

Clinical trials can be improved by managing the learning curve

July 29, 2010 10:34 pm | by EurekAlert | News | Comments

(Duke University Medical Center) Researchers at Duke University Medical Center looked for a learning curve phenomenon in the data record of a large, multi-site clinical trial. Their findings point to ways to improve the quality of future trials through better training and simulation exercises.

Suresh named chair of anesthesiology at Baylor College of Medicine

July 29, 2010 8:34 am | by Baylor College of Medicine | News | Comments

Dr. Maya S. Suresh was named chair of the Department of Anesthesiology at Baylor College of Medicine by the college's board of trustees Wednesday. "Dr. Suresh has a clear vision for the future of this important discipline at Baylor College of Medicine," said Dr. Stephen Spann, senior vice...

Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis

July 28, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

HORSHAM, Pa. , July 28 /- Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading